Skip to content

The effect of expressive writing on depression, anxiety, stress, and sleep quality of infertile women

The effect of expressive writing on depression, anxiety, stress ,and sleep quality of infertile women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091001002531N6
Enrollment
102
Registered
2022-02-01
Start date
2022-02-03
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Stress. Condition 3: Quality of sleep. Condition 4: Depression. Anxiety disorder due to known physiological condition Reaction to severe stress, and adjustment disorders Insufficient sleep syndrome Major depressive disorder, single episode

Interventions

Intervention 1: Intervention group: In this group, participants are taught to write for 3 days, every day for 20 minutes , their deepest feelings and worries and thoughts about not having a child and

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Diagnosed infertility Candidate for assisted reproductive therapy Married Anxiety and depression scores above 10 and sleep quality score above 5 Age of 18 - 45 years Having high school diploma or higher education

Exclusion criteria

Exclusion criteria: Infertile women candidate for surrogacy or ovule donation Infertile women with severe anxiety and depression scores Infertile women referring to a psychologist or psychiatrist during study Infertile women participating simultaneously in other researches related to the treatment of anxiety, depression, stress, and sleep disorders

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before expressive writing , Immediately after expressive writing, and 2 weeks after expressive writing. Method of measurement: Using Depression questionnaire DASS-21.;Anxiety. Timepoint: Before expressive writing , Immediately after expressive writing, and 2 weeks after expressive writing. Method of measurement: Using Anxiety questionnaire DASS-21.;Stress. Timepoint: Before expressive writing , Immediately after expressive writing, and 2 weeks after expressive writing. Method of measurement: Using Stress questionnaire DASS-21.;Quality of sleep. Timepoint: Before expressive writing , Immediately after expressive writing, and 2 weeks after expressive writing. Method of measurement: Using Sleep quality questionnaire of Pittsburg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahmineh Dadkhahtehrani

Esfahan University of Medical Sciences

tdtahmineh@gmail.com+98 31 3792 7596

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026